Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities

Hung Y. Lin, Harshad R. Thacore, Faith B. Davis, Paul J. Davis

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Added to HeLa cells previously exposed to recombinant human interferon (IFN)-γ for 20 h, thyroid hormone [L-thyroxine (T4)] in physiological concentrations potentiates the antiviral action of IFN-γ by more than 100- fold in 4 h. We examined protein kinase activities for their contributions to the mechanism of this posttranslational effect of thyroid hormone. Added concurrently with thyroid hormone, the protein kinase C (PKC) inhibitor CGP- 41251 (5 nM) blocked T4 potentiation of IFN-γ action. Coincubated with CGP- 41251, phorbol 12-myristate 13-acetate (PMA) reversed the effect of the inhibitor on thyroid hormone action. U-73122 (10 nM), a phospholipase C inhibitor, also blocked hormone potentiation. KT-5720 (500 nM), a protein kinase A (PKA) inhibitor, completely inhibited the T4 effect, whereas 8- bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP) restored hormone action in the presence of KT-5720. In the absence of T4, 8-BrcAMP and PMA, added together to cells in the 4-h paradigm, fully reproduced hormone potentiation of the antiviral effect of IFN-γ. Incubated individually with IFN-γ- treated cells, the two agonists had no potentiating action. Thyroid hormone apparently must activate both PKA and PKC in the nongenomic pathway of IFN- γ action to enhance antiviral activity in HeLa cells.

Original languageEnglish
JournalAmerican Journal of Physiology - Cell Physiology
Volume271
Issue number4 40-4
Publication statusPublished - Oct 1996
Externally publishedYes

Fingerprint

Cyclic AMP-Dependent Protein Kinases
Thyroxine
Protein Kinase C
Interferons
Antiviral Agents
Thyroid Hormones
4'-N-benzoylstaurosporine
Hormones
Protein Kinase Inhibitors
HeLa Cells
Acetates
8-Bromo Cyclic Adenosine Monophosphate
Protein C Inhibitor
Type C Phospholipases
Protein Kinases
Cells

Keywords

  • antiviral action
  • protein kinase A
  • protein kinase C
  • thyroid hormone

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology
  • Physiology (medical)

Cite this

Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities. / Lin, Hung Y.; Thacore, Harshad R.; Davis, Faith B.; Davis, Paul J.

In: American Journal of Physiology - Cell Physiology, Vol. 271, No. 4 40-4, 10.1996.

Research output: Contribution to journalArticle

@article{8cc64c2dcaa44112aaeb596f71c5980d,
title = "Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities",
abstract = "Added to HeLa cells previously exposed to recombinant human interferon (IFN)-γ for 20 h, thyroid hormone [L-thyroxine (T4)] in physiological concentrations potentiates the antiviral action of IFN-γ by more than 100- fold in 4 h. We examined protein kinase activities for their contributions to the mechanism of this posttranslational effect of thyroid hormone. Added concurrently with thyroid hormone, the protein kinase C (PKC) inhibitor CGP- 41251 (5 nM) blocked T4 potentiation of IFN-γ action. Coincubated with CGP- 41251, phorbol 12-myristate 13-acetate (PMA) reversed the effect of the inhibitor on thyroid hormone action. U-73122 (10 nM), a phospholipase C inhibitor, also blocked hormone potentiation. KT-5720 (500 nM), a protein kinase A (PKA) inhibitor, completely inhibited the T4 effect, whereas 8- bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP) restored hormone action in the presence of KT-5720. In the absence of T4, 8-BrcAMP and PMA, added together to cells in the 4-h paradigm, fully reproduced hormone potentiation of the antiviral effect of IFN-γ. Incubated individually with IFN-γ- treated cells, the two agonists had no potentiating action. Thyroid hormone apparently must activate both PKA and PKC in the nongenomic pathway of IFN- γ action to enhance antiviral activity in HeLa cells.",
keywords = "antiviral action, protein kinase A, protein kinase C, thyroid hormone",
author = "Lin, {Hung Y.} and Thacore, {Harshad R.} and Davis, {Faith B.} and Davis, {Paul J.}",
year = "1996",
month = "10",
language = "English",
volume = "271",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "4 40-4",

}

TY - JOUR

T1 - Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities

AU - Lin, Hung Y.

AU - Thacore, Harshad R.

AU - Davis, Faith B.

AU - Davis, Paul J.

PY - 1996/10

Y1 - 1996/10

N2 - Added to HeLa cells previously exposed to recombinant human interferon (IFN)-γ for 20 h, thyroid hormone [L-thyroxine (T4)] in physiological concentrations potentiates the antiviral action of IFN-γ by more than 100- fold in 4 h. We examined protein kinase activities for their contributions to the mechanism of this posttranslational effect of thyroid hormone. Added concurrently with thyroid hormone, the protein kinase C (PKC) inhibitor CGP- 41251 (5 nM) blocked T4 potentiation of IFN-γ action. Coincubated with CGP- 41251, phorbol 12-myristate 13-acetate (PMA) reversed the effect of the inhibitor on thyroid hormone action. U-73122 (10 nM), a phospholipase C inhibitor, also blocked hormone potentiation. KT-5720 (500 nM), a protein kinase A (PKA) inhibitor, completely inhibited the T4 effect, whereas 8- bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP) restored hormone action in the presence of KT-5720. In the absence of T4, 8-BrcAMP and PMA, added together to cells in the 4-h paradigm, fully reproduced hormone potentiation of the antiviral effect of IFN-γ. Incubated individually with IFN-γ- treated cells, the two agonists had no potentiating action. Thyroid hormone apparently must activate both PKA and PKC in the nongenomic pathway of IFN- γ action to enhance antiviral activity in HeLa cells.

AB - Added to HeLa cells previously exposed to recombinant human interferon (IFN)-γ for 20 h, thyroid hormone [L-thyroxine (T4)] in physiological concentrations potentiates the antiviral action of IFN-γ by more than 100- fold in 4 h. We examined protein kinase activities for their contributions to the mechanism of this posttranslational effect of thyroid hormone. Added concurrently with thyroid hormone, the protein kinase C (PKC) inhibitor CGP- 41251 (5 nM) blocked T4 potentiation of IFN-γ action. Coincubated with CGP- 41251, phorbol 12-myristate 13-acetate (PMA) reversed the effect of the inhibitor on thyroid hormone action. U-73122 (10 nM), a phospholipase C inhibitor, also blocked hormone potentiation. KT-5720 (500 nM), a protein kinase A (PKA) inhibitor, completely inhibited the T4 effect, whereas 8- bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP) restored hormone action in the presence of KT-5720. In the absence of T4, 8-BrcAMP and PMA, added together to cells in the 4-h paradigm, fully reproduced hormone potentiation of the antiviral effect of IFN-γ. Incubated individually with IFN-γ- treated cells, the two agonists had no potentiating action. Thyroid hormone apparently must activate both PKA and PKC in the nongenomic pathway of IFN- γ action to enhance antiviral activity in HeLa cells.

KW - antiviral action

KW - protein kinase A

KW - protein kinase C

KW - thyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=0029859219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029859219&partnerID=8YFLogxK

M3 - Article

C2 - 8897832

AN - SCOPUS:0029859219

VL - 271

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 4 40-4

ER -